The field of Precision Medicine is rapidly advancing, revolutionizing cancer diagnostics with molecular biomarkers that enable diagnostic classification, prognostic risk stratification, and therapeutic risk prediction. However, this progress is accompanied by several challenges that demand innovative solutions. This plenary lecture aims to explore the hurdles encountered in Precision Medicine and propose strategies to overcome them.

Learning Objectives:

• Summarize the reasons for growth of Precision Medicine-based testing

• Review challenges that are impacting the growth of Precision Medicine

• Identify opportunities to enhance clinically appropriate testing to enhance the practice of Precision Medicine